Tag: SciClone

Eisai

Eisai Enters Into License Agreement with SciClone for Development and Commercialization of Tasulgratinib in China, Hong Kong, Macau and Taiwan

Eisai Co., Ltd. announced that it has signed a license agreement with SciClone Pharmaceuticals Limited to grant exclusive…

By

NewsDesk

Join Our Community

First Name

Last Name

Email Address

Country

I have read and agree to the Terms & Conditions

Join Our Community

First Name

Last Name

Email Address

Country

I have read and agree to the Terms & Conditions